251 related articles for article (PubMed ID: 35127393)
1. A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer.
Sun D; Zou Y; Song L; Han S; Yang H; Chu D; Dai Y; Ma J; O'Driscoll CM; Yu Z; Guo J
Acta Pharm Sin B; 2022 Jan; 12(1):378-393. PubMed ID: 35127393
[TBL] [Abstract][Full Text] [Related]
2. Emerging role of natural products in cancer immunotherapy.
Dong S; Guo X; Han F; He Z; Wang Y
Acta Pharm Sin B; 2022 Mar; 12(3):1163-1185. PubMed ID: 35530162
[TBL] [Abstract][Full Text] [Related]
3. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
4. Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy.
Ma X; Yang S; Zhang T; Wang S; Yang Q; Xiao Y; Shi X; Xue P; Kang Y; Liu G; Sun ZJ; Xu Z
Acta Pharm Sin B; 2022 Jan; 12(1):451-466. PubMed ID: 35127398
[TBL] [Abstract][Full Text] [Related]
5. The copper (II) complex of salicylate phenanthroline induces immunogenic cell death of colorectal cancer cells through inducing endoplasmic reticulum stress.
Chen M; Wang D; Fan L; Niu D; Xu J; Liu Y; Liu Y
Int Immunopharmacol; 2024 May; 132():111980. PubMed ID: 38555819
[TBL] [Abstract][Full Text] [Related]
6. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
7. A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer.
Zou Y; Xiao F; Song L; Sun B; Sun D; Chu D; Wang L; Han S; Yu Z; O'Driscoll CM; Guo J
Int J Pharm; 2021 Sep; 606():120888. PubMed ID: 34271152
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti-cancer evaluation of peritumoral hydrogel injection combined with PD-L1 antibody.
Wu H; Wei G; Luo L; Li L; Gao Y; Tan X; Wang S; Chang H; Liu Y; Wei Y; Song J; Zhang Z; Huo J
Biomater Res; 2022 Dec; 26(1):77. PubMed ID: 36494759
[TBL] [Abstract][Full Text] [Related]
9. Application of PD-1 Blockade in Cancer Immunotherapy.
Wu X; Gu Z; Chen Y; Chen B; Chen W; Weng L; Liu X
Comput Struct Biotechnol J; 2019; 17():661-674. PubMed ID: 31205619
[TBL] [Abstract][Full Text] [Related]
10. Hollow Cu2MoS4 nanoparticles loaded with immune checkpoint inhibitors reshape the tumor microenvironment to enhance immunotherapy for pancreatic cancer.
Yao Z; Qi C; Zhang F; Yao H; Wang C; Cao X; Zhao C; Wang Z; Qi M; Yao C; Wang X; Xia H
Acta Biomater; 2024 Jan; 173():365-377. PubMed ID: 37890815
[TBL] [Abstract][Full Text] [Related]
11. Immunogenic Cell Death Induced by Ginsenoside Rg3: Significance in Dendritic Cell-based Anti-tumor Immunotherapy.
Son KJ; Choi KR; Lee SJ; Lee H
Immune Netw; 2016 Feb; 16(1):75-84. PubMed ID: 26937234
[TBL] [Abstract][Full Text] [Related]
12. Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma.
Guo J; Yu Z; Sun D; Zou Y; Liu Y; Huang L
Mol Cancer; 2021 Jan; 20(1):10. PubMed ID: 33407548
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells.
Zhu Y; Wang A; Zhang S; Kim J; Xia J; Zhang F; Wang D; Wang Q; Wang J
J Adv Res; 2023 Jul; 49():159-173. PubMed ID: 36167294
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic gene modified cell based cancer vaccines.
Kozłowska A; Mackiewicz J; Mackiewicz A
Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
[TBL] [Abstract][Full Text] [Related]
15. An innovative nanoformulation utilizing tumor microenvironment-responsive PEG-polyglutamic coating and dynamic charge adjustment for specific targeting of ER stress inducer, microRNA, and immunoadjuvant in pancreatic cancer: In vitro investigations.
Li CY; Chou TF; Lo YL
Int J Biol Macromol; 2024 Jan; 254(Pt 2):127905. PubMed ID: 37939778
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled FeS-based cascade bioreactor with enhanced tumor penetration and synergistic treatments to trigger robust cancer immunotherapy.
Ren H; Yong J; Yang Q; Yang Z; Liu Z; Xu Y; Wang H; Jiang X; Miao W; Li X
Acta Pharm Sin B; 2021 Oct; 11(10):3244-3261. PubMed ID: 34729313
[TBL] [Abstract][Full Text] [Related]
17. Nanodelivery of scutellarin induces immunogenic cell death for treating hepatocellular carcinoma.
Li L; Zou Y; Wang L; Yang L; Li Y; Liao A; Chen Z; Yu Z; Guo J; Han S
Int J Pharm; 2023 Jul; 642():123114. PubMed ID: 37301243
[TBL] [Abstract][Full Text] [Related]
18. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
19. Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer.
Han S; Bi S; Guo T; Sun D; Zou Y; Wang L; Song L; Chu D; Liao A; Song X; Yu Z; Guo J
J Control Release; 2022 Aug; 348():250-263. PubMed ID: 35660631
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression.
Kim M; Lee JS; Kim W; Lee JH; Jun BH; Kim KS; Kim DE
J Control Release; 2022 Aug; 348():893-910. PubMed ID: 35760233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
